Skip to main content
SpringerLink
Log in

Patient with Essential Hypertension and Left Ventricular Enlargement

  • Chapter
  • First Online:
Hypertension and Cardiac Organ Damage

Part of the book series: Practical Case Studies in Hypertension Management ((PCSHM))

  • 616 Accesses

Abstract

Please check if the section headings are assigned to appropriate levels.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: the task force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34(28):2159–219.

    Article  PubMed  Google Scholar 

  2. de Simone G, Izzo R, Aurigemma GP, De Marco M, Rozza F, Trimarco V, et al. Cardiovascular risk in relation to a new classification of hypertensive left ventricular geometric abnormalities. J Hypertens. 2015;33(4):745–54. discussion 54

    Article  PubMed  Google Scholar 

  3. Malacco E, Omboni S, Volpe M, Auteri A, Zanchetti A, Group ES. Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly patients with mild to moderate essential hypertension: the ESPORT study. J Hypertens. 2010;28(11):2342–50.

    Article  CAS  PubMed  Google Scholar 

  4. Tsutamoto T, Nishiyama K, Yamaji M, Kawahara C, Fujii M, Yamamoto T, et al. Comparison of the long-term effects of candesartan and olmesartan on plasma angiotensin II and left ventricular mass index in patients with hypertension. Hypertens Res. 2010;33(2):118–22.

    Article  CAS  PubMed  Google Scholar 

  5. Sukumaran V, Watanabe K, Veeraveedu PT, Thandavarayan RA, Gurusamy N, Ma M, et al. Beneficial effects of olmesartan, an angiotensin II receptor type 1 antagonist, in rats with dilated cardiomyopathy. Exp Biol Med. 2010;235(11):1338–46.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hypertension Research Center (CIRIAPA), University of Naples Federico II, Naples, Italy

    Raffaele Izzo

Authors
  1. Raffaele Izzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Izzo, R. (2017). Patient with Essential Hypertension and Left Ventricular Enlargement. In: Hypertension and Cardiac Organ Damage. Practical Case Studies in Hypertension Management. Springer, Cham. https://doi.org/10.1007/978-3-319-56080-9_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-56080-9_5

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-56079-3

  • Online ISBN: 978-3-319-56080-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation